clinical samples News
-
Simon Fraser University shares research results using COVID-19 testing system by Lumex Instruments
The results of the study have been published in The Journal of Molecular Diagnostics. According to the results, the Lumex Instruments’ COVID-19 test kit provides accurate and reliable results in 30 minutes with 10 times fewer reagents spent than tube-based PCR tests. “So it’s 10 times less expensive, roughly speaking”, said Peter Unrau, an SFU molecular biology and ...
-
Specific Diagnostics Commences US Clinical Trials for FDA 510(k) Clearance of its Reveal Rapid AST System
Specific Diagnostics announces today the commencement of its US clinical studies for the Reveal Rapid AST System for blood infection. Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the Reveal test. In Europe, where the Reveal is launched under CE-IVD registration, 11 studies across France and England comprising over 1,400 ...
-
Thermo Fisher Scientific Announces Collaborations to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances strengthen the PMSC's mission of creating ...
-
CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service
CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. Viruses, being the most abundant entities on our planet, play a pivotal ...
By CD Genomics
-
Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit is a rapid, accurate and straightforward point-of-care test kit that qualitatively detects IgM and IgG antibodies against the virus that causes COVID-19.
The test detects specific SARS CoV2 IgG and IgM antibodies in the blood in response to a coronavirus infection. The detection of antibodies can be used to identify those who have already had contact with the virus. IgG may remain elevated for up to several months and possibly years, which could help determine who has been exposed to the coronavirus, even if a person did not exhibit any symptoms ...
-
Creative Proteomics Launches Oncology Multi-omics Platform to Promote Basic Oncology Research
Using its mature multi-omics technology platform, Creative Proteomics has been devoted to providing high-quality, personalized oncology multi-omics services and reliable data support to worldwide clients for years. With the continuous aging of human society, the improvement of industrialization, and the deterioration of the quality of living environment, the incidence of cancer is getting ...
-
Detecting diseases in the palm of your hand
Portable laboratories the size of your palm, capable of analysing food for diseases such as salmonella, no longer belong in the realms of science fiction. A team of European researchers are on the fast track to producing just such a lab. OptoLabCard, a project funded by the EU to the tune of over EUR 3 million, offers to not only protect the health and well-being of millions of Europeans but also ...
-
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together Thermo ...
-
ABBOTT INFORMATICS LAUNCHES STARLIMS PUBLIC HEALTH SOLUTION PH12.0
Hollywood, FL - Abbott Informatics is pleased to announce the launch of the STARLIMS Public Health Solution PH12.0. Abbott Informatics has the STARLIMS Public Health (PH) Solution product currently deployed in laboratories throughout the United States. Nevertheless, enhancements need to continuously be added in order for our product to satisfy evolving market needs. Newborn screening is one such ...
-
Clinical Trial Design - This year`s most popular topics
About the webinar In this free webinar, we focus on some of the most popular trial design topics covered this year. To see video, please click here In this free webinar you will learn about: Guide to Sample Size Re-estimation in Clinical Trials Unblinded Sample Size Re-estimation Sample Size for Complex Endpoints Sample Size for Win Ratio Statistic Sample Size for Win Ratio Statistic ...
By Statsol
-
Selux Diagnostics Announces Selection of Three Abstracts for Poster Sessions at ASM Microbe 2019 Conference
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat multidrug resistant organism infections and combat antibiotic resistance, today announced the selection of three Selux-crafted abstracts for poster sessions at the upcoming American Society for Microbiology, ASM Microbe 2019 scientific meeting on June 20-24 in San Francisco. "Selux Diagnostics is dedicated to ...
-
SAGA expands research collaboration with University College London Cancer Institute
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announced an expanded research collaboration with Professor Charles Swanton, at the University College London (UCL) Cancer Institute. Last year, SAGA and UCL entered into a research collaboration on a limited number of ...
-
Sherlock Biosciences Announces Initial Results of Automation Study with NorDx Laboratories on CRISPR-based Test for SARS-CoV-2
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced initial results from an automation study of its CRISPR-based test for SARS-CoV-2 in partnership with NorDx Laboratories, a member of MaineHealth – a recognized leader in New England and Maine’s largest integrated healthcare system. The study ...
-
INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV-associated diseases, today announced the company is rapidly moving to evaluate its COVID-19 DNA vaccine candidates INO-4800 and INO-4802 against the emerging B.1.1.529 (Omicron) variant of concern. Concurrently, INOVIO ...
-
Guide to Sample Size Re-Estimation in Clinical Trials
About the webinar We explore common challenges faced when designing and conducting clinical trials with sample size re-estimation (SSR). Common SSR methods are explored along with their pros and cons. We have also examined some real-world examples of these methods, while taking a look at what advantages their use can bring. Further below, you will find the webinar recording, slides and worked ...
By Statsol
-
CD Formulation Empowers High-volume Manufacturing of Microspheres
Over the past decade, innovation in the field of microsphere production has reached new heights. Thanks to groundbreaking technology, CD Formulation has enabled mass production services for these versatile particles. Through a cutting-edge approach, CD Formulation is well-prepared to serve the industry by offering efficient and effective solutions for the mass fabrication of microspheres. From ...
-
Indee Labs Awarded Grant from the National Institute of Allergy & Infectious Disease
Indee Labs is a biotechnology company developing the µVS Delivery SystemTM for non-viral intracellular or gene delivery. The team at Indee Labs was awarded a grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop the µVS Delivery SystemTM for modified regulatory T cells. ...
By Indee Labs
-
Improving Sample Size Using Bayesian Thinking
About the webinar In this webinar, we explored some of the issues faced when statistical power is used as the sole metric for trial success when conducting a sample size determination. We showed how Bayesian assurance can be used as a complementary metric, that allows parameter uncertainty to be formally incorporated into the trial design. We also discuss some of the limitations of using a ...
By Statsol
-
Indee Labs Awarded Contract from the National Cancer Institute
Indee Labs is a biotechnology company developing the µVS Delivery SystemTM for non-viral intracellular or gene delivery. The team at Indee Labs was recently awarded a contract from the National Cancer Institute to develop the µVS Delivery SystemTM for T cell immunotherapy discovery, development and manufacturing. “T cell immunotherapies have ...
By Indee Labs
-
Specific Diagnostics Announces the Formation of its US Commercial Team and Introduction of the Reveal Rapid AST System to the US Market
Specific Diagnostics today announced formation of its US commercial sales, service, support and marketing teams in anticipation of the launch of the Reveal Rapid AST System for blood infection samples. Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, and in tandem with the commencement of clinical and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you